← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Brookdale grew revenue and turned FCF positive, but net loss widened, debt rose, and equity turned negative.
The read at a glance✓ Audited against SEC data
- Business mix — Senior living communitiesNote
- Revenue — Revenue up 2.2%OK
- Loss — Net loss widened 30.1%Watch
- FCF — FCF improved to $16.5MOK
- Balance sheet — Equity turned negativeWatch
- Insiders — 0 purchases / 0 salesNote
- Accounting — Altman-Z distress; Beneish clean; EQ safeWatch
Business
Brookdale operates and manages independent living, assisted living, memory care, and continuing care retirement communities.
Where the revenue comes from
Fiscal 2025, as Brookdale Senior Living Inc. reports it. History and quarterly detail are in the app.
- Assisted Living and Memory Care$2.1B
- Independent Living$593.8M
- CCRCs$345.6M
- All Other$151.4M
Leadership changes
From Brookdale Senior Living Inc.'s own filings, the day they're filed.
- Mary Sue Patchett · President · appointmenteff. 2025-12-01
- Nikolas W. Stengle · Chief Executive Officer · appointmenteff. 2025-10-06
- Frank M. Bumstead · departureeff. 2025-04-24
Latest filings
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-07-09
- 8-K · Company announcement2026-06-24
- 10-Q · Quarterly report2026-05-07
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- Main tension🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Brookdale Senior Living Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.